Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Distillers Company was a major British industrial conglomerate that operated a significant pharmaceutical division, Distillers Company (Biochemicals) Ltd, during the mid-20th century. Originally focused on spirits and yeast, the company became a pioneer in the mass production of penicillin during World War II, establishing a large-scale manufacturing facility in Speke, Liverpool. The company is most historically significant in the medical field for licensing and distributing thalidomide under the brand name Distaval in the United Kingdom and Australia. Following the thalidomide tragedy, the company faced extensive litigation and eventually sold its pharmaceutical interests to Eli Lilly in 1962. The parent company was later the subject of a high-profile takeover by Guinness in 1986, which eventually led to the formation of Diageo. Today, the company's legacy in the life sciences is primarily studied through the lens of drug regulation and corporate responsibility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Distillers Company.